Current Cancer Therapy Reviews

Editor-in-Chief

Yangchao Chen
School of Biomedical Sciences
Faculty of Medicine
The Chinese University of Hong Kong
Shatin
(Hong Kong)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 4 Issue: 1, February

Recent Advances in T Cell Adoptive Immunotherapy of Cancer

Volume:4   Issue: 1
Pp: 1-13
Li Zhang and Pouneh Dokouhaki
DOI: 10.2174/157339408783565475
Published on: 01 March, 2012

Apoptosis Signaling Pathways in Anticancer Therapy

Volume:4   Issue: 1
Pp: 14-20
Simone Fulda and Klaus-Michael Debatin
DOI: 10.2174/157339408783565510
Published on: 01 March, 2012

The Role of Nucleoside Transport in the Antineoplastic Activity of Purine Nucleoside Chemotherapeutic Agents

Volume:4   Issue: 1
Pp: 21-30
Carol E. Cass and Karen M. King
DOI: 10.2174/157339408783565501
Published on: 01 March, 2012

Membrane Tyrosine Kinase Receptors are an Important Target for the Therapy of Acute Myeloid Leukemia

Volume:4   Issue: 1
Pp: 31-49
Ugo Testa
DOI: 10.2174/157339408783565466
Published on: 01 March, 2012

Cancer Therapeutics: Emerging Targets and Trends

Volume:4   Issue: 1
Pp: 50-56
Mohd. Fahad Ullah
DOI: 10.2174/157339408783565493
Published on: 01 March, 2012

HER2 in the Era of Molecular Medicine: A Review

Volume:4   Issue: 1
Pp: 57-65
Karen A. Callaghan, Rachel E. Ellsworth, Darrell L. Ellsworth and Craig D. Shriver
DOI: 10.2174/157339408783565529
Published on: 01 March, 2012

Molecular Replacement in Cancer Therapy: Reversing Cancer Metabolic and Mitochondrial Dysfunction, Fatigue and the Adverse Effects of Cancer Therapy

Volume:4   Issue: 1
Pp: 66-76
Garth L. Nicolson and Kenneth A. Conklin
DOI: 10.2174/157339408783565484
Published on: 01 March, 2012